Pulmatrix Inc (PULM): PUR1800 Tox Results in Q3 2021; JnJ s...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: None

Monday, 07/12/2021 9:22:44 AM

Monday, July 12, 2021 9:22:44 AM

PUR1800 Tox Results in Q3 2021;

JnJ seems likely to re-enter for Lung Cancer Indication upon chronic dosage showing safety levels.

$PULM

All comments are solely my opinion. Please formulate your own opinion and act on your own accord on all actions you take.

Keep Last Read

Replies (1) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:06:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 02:00:24 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 02:20:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 02:05:40 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 01:20:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 01:05:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 08:05:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 01:05:21 PM